Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Alí Duarte‐García"'
Publikováno v:
Journal of General Internal Medicine
Autor:
A. Jayatilleke, Jourdan Frankovich, Brittany A. Frankel, Yu Pei Chock, Irvin J Huang, Adam Kilian, Elizabeth R. Graef, Kristen J. Young, Sindhu R. Johnson, Kanika Monga, Sonia D. Silinsky Krupnikova, Carly Harrison, Michael S. Putman, Aneka Khilnani, Jean W. Liew, Jeffrey A. Sparks, Jorge A. Rosario Vega, Bharat Kumar, Ibrahim Almaghlouth, Alí Duarte-García, Laura A. Upton, Zachary S. Wallace, Namrata Singh, Rebecca Grainger, Ruth Fernandez-Ruiz, Laura C. Cappelli, Elaine Sullo
Publikováno v:
Seminars in Arthritis and Rheumatism
Highlights • This scoping review provides an up-to-date overview of published evidence regarding the frequency and severity of acute viral respiratory AEs related to antirheumatic disease therapies. • Glucocorticoid use was associated with a high
Autor:
Thomas L. Ortel, Hannah Cohen, Maria G Tektonidou, Doruk Erkan, Anisur Rahman, David J. Williams, Jason S. Knight, David A. Isenberg, Rohan Willis, Alí Duarte-García, Maria José Cuadrado, Jane E. Salmon, Scott C. Woller, Danieli Andrade
Publikováno v:
Lupus
Antiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid antibodies. The 16th International Congress on Antiphospholipid Antibodie
Publikováno v:
Current Opinion in Rheumatology. 32:215-227
Purpose of review Antiphospholipid syndrome (APS), more common than once believed, is an autoimmune disease best known for its high risk of incident and recurrent thrombotic events. The approach to treatment potentially differs from treatment of thro
Autor:
Wendy M. Smith, Andrew J. Barkmeier, Thomas J. O'Byrne, Mehmet Hocaoglu, Jesse Y Dabit, Cynthia S. Crowson, Kevin G. Moder, Alí Duarte-García
Publikováno v:
Rheumatology (Oxford)
Objectives We aimed to estimate the risk of HCQ retinopathy and its risk factors among incident users in the community. Methods Using the Rochester Epidemiology Project, a record-linkage system, a cohort of incident users of HCQ was identified from 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::330c9eca70b4baa91b6cf27bdaa03eb7
https://europepmc.org/articles/PMC9348760/
https://europepmc.org/articles/PMC9348760/
Autor:
Maria Margarida Cunha, Gabriela Schmajuk, Rebecca Hasseli, Namrata Singh, Tiffany Y.T. Hsu, Milena A. Gianfrancesco, Anja Strangfeld, Ranjeny Thomas, Naomi J Patel, Thierry Thomas, Philippe Dieudé, Kimme L. Hyrich, Emily Sirotich, Laura Trupin, Liselotte Tidblad, Jinoos Yazdany, René Marc Flipo, Licia Maria Henrique da Mota, Andrea M Seet, Samar Al Emadi, Carolina A. Isnardi, Saskia Lawson-Tovey, Alí Duarte-García, Hendrik Schulze-Koops, Manuel F. Ugarte-Gil, Vanessa L. Kronzer, Philip Robinson, Lindsay Jacobsohn, Elsa F Mateus, Pedro Machado, Ana Paula Monteiro Gomides, Jean W. Liew, Guillermo A. Berbotto, Miguel Bernardes, Patricia P. Katz, Martin Schäfer, Guillermo J. Pons-Estel, Ulf Müller-Ladner, Jeffrey A. Sparks, Elena Nikiphorou, Christof Specker, Paul Sufka, Zara Izadi, Loreto Carmona, Stephanie Rush, Sandra Lúcia Euzébio Ribeiro, Maria O Valenzuela-Almada, Kristin M. D’Silva, Emily L Gilbert, Raphaèle Seror, Laure Gossec, Beth I Wallace, Viviane Angelina de Souza, Akpabio Akpabio, Jérôme Avouac, Leanna Wise, Wendy Costello, Zachary S. Wallace, Suleman Bhana, Jonathan S. Hausmann, Lianne Kearsley-Fleet, Bernd Raffeiner, Carlo Alberto Scirè, Rebecca Grainger
Publikováno v:
Annals of the Rheumatic Diseases
Sparks, J A, Wallace, Z S, Seet, A M, Gianfrancesco, M A, Izadi, Z, Hyrich, K L, Strangfeld, A, Gossec, L, Carmona, L, Mateus, E F, Lawson-Tovey, S, Trupin, L, Rush, S, Katz, P, Schmajuk, G, Jacobsohn, L, Wise, L, Gilbert, E L, Duarte-García, A, Valenzuela-Almada, M O, Pons-Estel, G J, Isnardi, C A, Berbotto, G A, Hsu, T Y T, D'Silva, K M, Patel, N J, Kearsley-Fleet, L, Schäfer, M, Ribeiro, S L E, Al Emadi, S, Tidblad, L, Scirè, C A, Raffeiner, B, Thomas, T, Flipo, R M, Avouac, J, Seror, R, Bernardes, M, Cunha, M M, Hasseli, R, Schulze-Koops, H, Müller-Ladner, U, Specker, C, De Souza, V A, Da Mota, L M H, Gomides, A P M, Dieudé, P, Nikiphorou, E, Kronzer, V L, Singh, N, Ugarte-Gil, M F, Wallace, B, Akpabio, A, Thomas, R, Bhana, S, Costello, W, Grainger, R, Hausmann, J S, Liew, J W, Sirotich, E, Sufka, P, Robinson, P C, Machado, P M & Yazdany, J 2021, ' Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis : Results from the COVID-19 Global Rheumatology Alliance physician registry ', Annals of the rheumatic diseases, vol. 80, no. 9, pp. 1137-1146 . https://doi.org/10.1136/annrheumdis-2021-220418
Sparks, J A, Wallace, Z S, Seet, A M, Gianfrancesco, M A, Izadi, Z, Hyrich, K L, Strangfeld, A, Gossec, L, Carmona, L, Mateus, E F, Lawson-Tovey, S, Trupin, L, Rush, S, Katz, P, Schmajuk, G, Jacobsohn, L, Wise, L, Gilbert, E L, Duarte-García, A, Valenzuela-Almada, M O, Pons-Estel, G J, Isnardi, C A, Berbotto, G A, Hsu, T Y T, D'Silva, K M, Patel, N J, Kearsley-Fleet, L, Schäfer, M, Ribeiro, S L E, Al Emadi, S, Tidblad, L, Scirè, C A, Raffeiner, B, Thomas, T, Flipo, R M, Avouac, J, Seror, R, Bernardes, M, Cunha, M M, Hasseli, R, Schulze-Koops, H, Müller-Ladner, U, Specker, C, De Souza, V A, Da Mota, L M H, Gomides, A P M, Dieudé, P, Nikiphorou, E, Kronzer, V L, Singh, N, Ugarte-Gil, M F, Wallace, B, Akpabio, A, Thomas, R, Bhana, S, Costello, W, Grainger, R, Hausmann, J S, Liew, J W, Sirotich, E, Sufka, P, Robinson, P C, Machado, P M & Yazdany, J 2021, ' Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis : Results from the COVID-19 Global Rheumatology Alliance physician registry ', Annals of the rheumatic diseases, vol. 80, no. 9, pp. 1137-1146 . https://doi.org/10.1136/annrheumdis-2021-220418
ObjectiveTo investigate baseline use of biologic or targeted synthetic (b/ts) disease-modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA).MethodsWe analysed the COVID-19 Global Rheumatology Alliance physician reg
Antirheumatic disease therapies for the treatment of COVID‐19: A systematic review and meta‐analysis
Autor:
Alfred H.J. Kim, Adam Kilian, Sindhu R. Johnson, Maria I. Danila, Herman Tam, Jean W. Liew, Michael S. Putman, Peter Korsten, Catalina Sanchez-Alvarez, M. Hassan Murad, Francis Berenbaum, Yu Pei Eugenia Chock, Arundathi Jayatilleke, Andrea Peirce, Laura C Coates, Sebastian E. Sattui, Larry J. Prokop, Rebecca Grainger, Candace A Palmerlee, Zachary S. Wallace, Jeffrey A. Sparks, Alí Duarte-García
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Arthritis & Rheumatology
Arthritis & Rheumatology
Objective Antirheumatic disease therapies have been used to treat coronavirus disease 2019 (COVID‐19) and its complications. We conducted a systematic review and meta‐analysis to describe the current evidence. Methods A search of published and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::066040af512dafa98b89f3ad05fa81ec
https://doi.org/10.1002/art.41469
https://doi.org/10.1002/art.41469
Autor:
Ariella Coler-Reilly, Peter Korsten, Alí Duarte-García, Emily Sirotich, Sebastian E. Sattui, Francis Berenbaum, Carly Harrison, Jeffrey A. Sparks, Manuel F. Ugarte-Gil, Maximilian F. Konig, Michael S. Putman, Jean W. Liew, Kate Webb, Kristen J. Young, Alfred H.J. Kim, Elizabeth R. Graef, Philip Robinson
Publikováno v:
Expert Review of Clinical Immunology
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Introduction Several months into the COVID-19 pandemic, safe and effective treatments against this global health disaster have yet to be identified. Clinical research trials around the world are underway testing a wide array of possible medications.
Autor:
Jean W. Liew, Maximilian F. Konig, Jeffrey A. Sparks, Elizabeth R. Graef, Alí Duarte-García, Alfred H.J. Kim
Publikováno v:
Annals of the Rheumatic Diseases
We appreciate the interest of Lo et al in our opinion piece and thank them for the data presented in their letter.1 2 Several reports of QT prolongation and torsades de pointes in patients with COVID-19 receiving antimalarials have been published.3
Autor:
Alfred H J, Kim, Jeffrey A, Sparks, Jean W, Liew, Michael S, Putman, Francis, Berenbaum, Alí, Duarte-García, Elizabeth R, Graef, Peter, Korsten, Sebastian E, Sattui, Emily, Sirotich, Manuel F, Ugarte-Gil, Kate, Webb, Rebecca, Grainger, Marc, Nolan
Publikováno v:
Annals of Internal Medicine
Annals of Internal Medicine, 2020, ⟨10.7326/M20-1223⟩
Annals of Internal Medicine, American College of Physicians, 2020, ⟨10.7326/M20-1223⟩
Annals of Internal Medicine, 2020, ⟨10.7326/M20-1223⟩
Annals of Internal Medicine, American College of Physicians, 2020, ⟨10.7326/M20-1223⟩
Hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has garnered widespread attention as a potential treatment for COVID-19 infection. The authors appraise t...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3db700f35b57719826799ff32b6c83cb
https://www.hal.inserm.fr/inserm-02552186
https://www.hal.inserm.fr/inserm-02552186